Pre-clinical characterization of GMP grade CCL21-gene modified dendritic cells for application in a phase I trial in Non-Small Cell Lung Cancer

BACKGROUND: Our previous studies have demonstrated that transduction of human dendritic cells (DC) with adenovirus encoding secondary lymphoid chemokine, CCL21, led to secretion of biologically active CCL21 without altering DC phenotype or viability. In addition, intratumoral injections of CCL21-tra...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Principais autores: Baratelli, Felicita, Takedatsu, Hiroko, Hazra, Saswati, Peebles, Katherine, Luo, Jie, Kurimoto, Pam S, Zeng, Gang, Batra, Raj K, Sharma, Sherven, Dubinett, Steven M, Lee, Jay M
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2008
Assuntos:
Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC2507704/
https://ncbi.nlm.nih.gov/pubmed/18644162
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1479-5876-6-38
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registros relacionados